Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis

被引:2
作者
Ang, Qi Yan
Plichta, Damian [1 ]
Kim, Sean [2 ]
Kim, Iris Hyun-A
Gregory, Sadie
Xia, Yan [1 ]
Lau, Helena [2 ]
Xavier, Ramnik [1 ,2 ,3 ,4 ]
Ananthakrishnan, Ashwin N. [2 ,3 ,5 ]
机构
[1] Broad Inst, Cambridge, MA USA
[2] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA USA
[5] Massachusetts Gen Hosp, Crohns & Colitis Ctr, 165 Cambridge St, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
Crohn's disease; ulcerative colitis; smoking; epigenetics; RNA-seq; methylation; INFLAMMATORY-BOWEL-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; POLYMORPHISMS; METHYLATION; EXPRESSION; SIGNATURES; MIGRATION; PACKAGE;
D O I
10.1093/ibd/izad268
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Smoking is an environmental factor that differentially impacts Crohn's disease (CD) and ulcerative colitis (UC). The mechanism of impact of smoking on disease risk and clinical outcomes remains to be established.Methods This study used a prospective cohort of patients with CD or UC. Self-reported smoking status was validated using serum cotinine measurement. We profiled methylation changes in peripheral blood using the Illumina Methylation BeadChip. Transcriptomic profiling was performed on ileal and colonic tissue using an Illumina TruSeq platform. We compared the methylation and transcriptional changes in current, former, and never smokers stratified by disease type.Results Our cohort included 200 patients with CD or UC with methylation profiles and 160 with transcriptomic data. The mean serum cotinine level was higher in current compared with former or never smokers. Epigenetic changes common to both CD and UC included hypomethylation at AHRR. Smoking-associated MGAT3 hypomethylation was associated with severe disease course only in UC, while IER3 hypomethylation was associated with worse course only in CD. Smoking downregulated several inflammatory pathways in UC. Current smoking in CD but not in UC was associated with upregulation of several genes mediating Paneth cell function. Genes with opposite direction of effects in CD and UC include HSD3B2 and GSTA1.Conclusions Our findings suggest both common and differential effects of cigarette smoking on CD and UC. Paneth cell dysfunction may mediate adverse impact of smoking on CD. Bile acid and oxidative stress pathways may be relevant for the differential effect of smoking on CD and UC. Smoking is a key environmental risk factor for the development of inflammatory bowel disease. Smoking induces changes differential epigenetic changes in the peripheral blood in Crohn's disease and ulcerative colitis. Smoking also induces down regulation of expression of various proinflammatory genes in the colon in ulcerative colitis.
引用
收藏
页码:981 / 991
页数:11
相关论文
共 50 条
  • [31] Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
    Gersemann, Michael
    Becker, Svetlana
    Kuebler, Irmgard
    Koslowski, Maureen
    Wang, Guoxing
    Herrlinger, Klaus Robert
    Griger, Joscha
    Fritz, Peter
    Fellermann, Klaus
    Schwab, Matthias
    Wehkamp, Jan
    Stange, Eduard Friedrich
    DIFFERENTIATION, 2009, 77 (01) : 84 - 94
  • [32] Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence
    Pedersen, Kasper Monsted
    Colak, Yunus
    Vedel-Krogh, Signe
    Kobylecki, Camilla Jannie
    Bojesen, Stig Egil
    Nordestgaard, Borge Gronne
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (07) : 735 - 745
  • [33] Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis
    Lehmann, T.
    Schallert, K.
    Vilchez-Vargas, R.
    Benndorf, D.
    Puettker, S.
    Sydor, S.
    Schulz, C.
    Bechmann, L.
    Canbay, A.
    Heidrich, B.
    Reichl, U.
    Link, A.
    Heyer, R.
    JOURNAL OF PROTEOMICS, 2019, 201 : 93 - 103
  • [34] Current position on Vedolizumab for ulcerative colitis and Crohn's disease
    Schreiber, S.
    Dignass, A. U.
    Hartmann, H.
    Kruis, W.
    Rogler, G.
    Siegmund, B.
    Stallmach, A.
    Witte, C.
    Bokemeyer, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (06): : 591 - 602
  • [35] A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
    Persaud, Alana
    Ahmed, Ahmed
    Kakked, Gaurav
    Shulik, Oleg
    Ahlawat, Sushil
    JGH OPEN, 2019, 3 (06): : 508 - 512
  • [36] Diagnosis of Crohn's disease and ulcerative colitis using the microbiome
    Kang, Da-Yeon
    Park, Jong-Lyul
    Yeo, Min-Kyung
    Kang, Sang-Bum
    Kim, Jin-Man
    Kim, Ju Seok
    Kim, Seon-Young
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [37] Clinical Features of Ulcerative Colitis and Crohn's Disease in Turkey
    Ozin, Yasemin
    Kilic, Mesut Zeki Yalin
    Nadir, Isilay
    Cakal, Basak
    Disibeyaz, Selcuk
    Arhan, Mehmet
    Dagli, Ulku
    Tunc, Bilge
    Ulker, Aysel
    Sahin, Burhan
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (02) : 157 - 162
  • [38] New biologic therapeutics for ulcerative colitis and Crohn's disease
    Mozaffari, Shilan
    Nikfar, Shekoufeh
    Abdolghaffari, Amir Hossein
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 583 - 600
  • [39] Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?
    Gilroy, Leah
    Allen, Patrick B.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 163 - 172
  • [40] Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease
    Yarani, Reza
    Shojaeian, Ali
    Palasca, Oana
    Doncheva, Nadezhda T.
    Jensen, Lars Juhl
    Gorodkin, Jan
    Pociot, Flemming
    FRONTIERS IN IMMUNOLOGY, 2022, 13